- Home
- TNXP vs AZ Comparison
TNXP vs AZ Comparison
Compare TNXP & AZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- AZ
- Stock Information
- Founded
- TNXP 2007
- AZ 2018
- Country
- TNXP United States
- AZ Canada
- Employees
- TNXP N/A
- AZ N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- AZ Industrial Machinery/Components
- Sector
- TNXP Health Care
- AZ Industrials
- Exchange
- TNXP Nasdaq
- AZ Nasdaq
- Market Cap
- TNXP 197.9M
- AZ 224.3M
- IPO Year
- TNXP N/A
- AZ N/A
- Fundamental
- Price
- TNXP $15.12
- AZ $7.01
- Analyst Decision
- TNXP Buy
- AZ Strong Buy
- Analyst Count
- TNXP 1
- AZ 1
- Target Price
- TNXP $70.00
- AZ $20.00
- AVG Volume (30 Days)
- TNXP 778.7K
- AZ 418.3K
- Earning Date
- TNXP 11-10-2025
- AZ 11-13-2025
- Dividend Yield
- TNXP N/A
- AZ N/A
- EPS Growth
- TNXP N/A
- AZ N/A
- EPS
- TNXP N/A
- AZ N/A
- Revenue
- TNXP $10,299,000.00
- AZ $7,463,000.00
- Revenue This Year
- TNXP $14.79
- AZ $1,343,857.60
- Revenue Next Year
- TNXP $933.49
- AZ N/A
- P/E Ratio
- TNXP N/A
- AZ N/A
- Revenue Growth
- TNXP N/A
- AZ 41.45
- 52 Week Low
- TNXP $6.76
- AZ $5.00
- 52 Week High
- TNXP $130.00
- AZ $12.36
- Technical
- Relative Strength Index (RSI)
- TNXP 35.51
- AZ 60.00
- Support Level
- TNXP $13.70
- AZ $5.12
- Resistance Level
- TNXP $18.25
- AZ $5.87
- Average True Range (ATR)
- TNXP 1.28
- AZ 0.47
- MACD
- TNXP 0.07
- AZ 0.19
- Stochastic Oscillator
- TNXP 26.08
- AZ 91.97
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About AZ A2Z Smart Technologies Corp.
A2Z Cust2Mate Solutions Corp is engaged in creating shopping carts. With the help of a user-friendly smart algorithm, touch screen, and other technologies, the company streamlines the retail shopping experience by scanning purchased products and enabling in-cart payment so that customers can simply pick & go, and bypass long cashier checkout lines.